speb/financial-data huggingface dataset:
CERS cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: 3000.00
CERS cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 3000.00
CERS cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
CERS income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 370000.00
CERS balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -400000.00
CERS balance_sheet (annual, 2024-12-31) — Goodwill: 1316000.00
CERS balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 1316000.00
CERS balance_sheet (annual, 2024-12-31) — Gross PPE: 33977000.00
CERS income_statement (annual, 2024-12-31) — Gross Profit: 99522000.00
CERS cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 356000.00
CERS income_statement (annual, 2024-12-31) — Interest Expense: 8877000.00
CERS income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 8877000.00
CERS cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 9295000.00
CERS balance_sheet (annual, 2024-12-31) — Inventory: 38150000.00
CERS balance_sheet (annual, 2024-12-31) — Invested Capital: 140304000.00
CERS cash_flow (annual, 2024-12-31) — Investing Cash Flow: -8130000.00
CERS cash_flow (annual, 2024-12-31) — Issuance Of Debt: 5000000.00
CERS balance_sheet (annual, 2024-12-31) — Leases: 12192000.00
CERS balance_sheet (quarterly, 2024-12-31) — Leases: 12192000.00
CERS balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 11663000.00
CERS balance_sheet (annual, 2024-12-31) — Long Term Debt: 64862000.00
CERS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 76525000.00
CERS cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 5000000.00
CERS cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -703000.00
CERS cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: 776000.00
CERS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 11926000.00
CERS balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 11926000.00
CERS balance_sheet (annual, 2024-12-31) — Minority Interest: 751000.00
CERS income_statement (annual, 2024-12-31) — Minority Interests: 43000.00
CERS balance_sheet (annual, 2024-12-31) — Net Debt: 63893000.00
CERS cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -388000.00
CERS income_statement (annual, 2024-12-31) — Net Income: -20918000.00
CERS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -20918000.00
CERS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -20961000.00
CERS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -20918000.00
CERS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -20918000.00
CERS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -20961000.00
CERS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -20961000.00
CERS income_statement (annual, 2024-12-31) — Net Interest Income: -8877000.00
CERS cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -5293000.00
CERS cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 4297000.00
CERS cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 4297000.00
CERS income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -8877000.00
CERS cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -137000.00
CERS cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -30000.00
CERS balance_sheet (annual, 2024-12-31) — Net PPE: 15538000.00
CERS cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -703000.00
CERS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 54829000.00
CERS income_statement (annual, 2024-12-31) — Normalized EBITDA: -10394000.00
CERS income_statement (annual, 2024-12-31) — Normalized Income: -21210300.00
CERS cash_flow (annual, 2024-12-31) — Operating Cash Flow: 11359000.00
CERS cash_flow (annual, 2024-12-31) — Operating Gains Losses: -378000.00
CERS income_statement (annual, 2024-12-31) — Operating Income: -14225000.00
CERS income_statement (annual, 2024-12-31) — Operating Revenue: 180270000.00
CERS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 185766000.00
CERS balance_sheet (annual, 2024-12-31) — Other Current Assets: 3643000.00
CERS balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 19297000.00
CERS balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -400000.00
CERS income_statement (annual, 2024-12-31) — Other Income Expense: 2346000.00
CERS cash_flow (annual, 2024-12-31) — Other Non Cash Items: 2880000.00
CERS balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 32041000.00
CERS balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 3888000.00
CERS income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 1976000.00
CERS income_statement (annual, 2024-12-31) — Other Operating Expenses: -21051000.00
CERS balance_sheet (annual, 2024-12-31) — Other Properties: 9859000.00
CERS balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 60186000.00
CERS balance_sheet (annual, 2024-12-31) — Payables: 21695000.00
CERS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 28699000.00
CERS balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 11939000.00
CERS balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CERS balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 0.00
CERS income_statement (annual, 2024-12-31) — Pretax Income: -20756000.00
CERS cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 804000.00
CERS balance_sheet (annual, 2024-12-31) — Properties: 0.00
CERS balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CERS cash_flow (annual, 2024-12-31) — Purchase Of Investment: -42975000.00
CERS balance_sheet (annual, 2024-12-31) — Receivables: 29777000.00
CERS income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 80748000.00
CERS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1855000.00
CERS cash_flow (annual, 2024-12-31) — Repayment Of Debt: -703000.00
CERS cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 776000.00
CERS income_statement (annual, 2024-12-31) — Research And Development: 58907000.00
CERS income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
CERS income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
CERS balance_sheet (annual, 2024-12-31) — Retained Earnings: -1065528000.00
CERS cash_flow (annual, 2024-12-31) — Sale Of Investment: 37682000.00
CERS income_statement (annual, 2024-12-31) — Selling General And Administration: 75891000.00
CERS balance_sheet (annual, 2024-12-31) — Share Issued: 185766000.00
CERS cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -703000.00
CERS income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
CERS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
CERS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 22867000.00
CERS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 56145000.00
CERS balance_sheet (annual, 2024-12-31) — Tangible Book Value: 54829000.00
CERS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 77700.00
CERS income_statement (annual, 2024-12-31) — Tax Provision: 205000.00
CERS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
CERS balance_sheet (annual, 2024-12-31) — Total Assets: 200917000.00
CERS balance_sheet (annual, 2024-12-31) — Total Capitalization: 121007000.00
CERS balance_sheet (annual, 2024-12-31) — Total Debt: 98097000.00
CERS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 56896000.00
CERS income_statement (annual, 2024-12-31) — Total Expenses: 194495000.00
CERS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 144021000.00
CERS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 48895000.00
CERS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 80413000.00
CERS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -14225000.00
CERS income_statement (annual, 2024-12-31) — Total Unusual Items: 370000.00
CERS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 370000.00
CERS cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -135000.00
CERS balance_sheet (annual, 2024-12-31) — Working Capital: 88414000.00
CERS income_statement (quarterly, 2025-03-31) — +Operating Expense: 31277000.00
CERS income_statement (quarterly, 2025-03-31) — +Total Revenue: 43239000.00
CERS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 27677000.00
CERS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 26344000.00
CERS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1128812000.00
CERS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 187066000.00
CERS income_statement (quarterly, 2025-03-31) — Basic EPS: -0.04
CERS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 21361000.00
CERS cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -112000.00
CERS cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -112000.00
CERS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 14473000.00
CERS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 191000.00
CERS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 19476000.00
CERS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 80919000.00
CERS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 1071000.00
CERS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -1189000.00
CERS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -844000.00
CERS cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 5037000.00
CERS cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -2426000.00
CERS cash_flow (quarterly, 2025-03-31) — Change In Inventory: -6333000.00
CERS cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 1051000.00
CERS cash_flow (quarterly, 2025-03-31) — Change In Payable: 5037000.00
CERS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 2611000.00
CERS cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -2312000.00
CERS cash_flow (quarterly, 2025-03-31) — Change In Receivables: 3661000.00
CERS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1322000.00
CERS cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 3661000.00
CERS cash_flow (quarterly, 2025-03-31) — Changes In Cash: -962000.00
CERS balance_sheet (quarterly, 2025-03-31) — Common Stock: 191000.00
CERS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 55492000.00
CERS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 17815000.00
CERS balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 7233000.00
CERS balance_sheet (quarterly, 2025-03-31) — Current Assets: 161515000.00
CERS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 2532000.00
CERS balance_sheet (quarterly, 2025-03-31) — Current Debt: 20097000.00
CERS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 22629000.00
CERS balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 2449000.00
CERS balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 2449000.00
CERS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 69690000.00
CERS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 307000.00
CERS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 307000.00
CERS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 187066000.00
CERS income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.04
CERS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -7717000.00
CERS income_statement (quarterly, 2025-03-31) — EBIT: -5534000.00
CERS income_statement (quarterly, 2025-03-31) — EBITDA: -5227000.00
CERS cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 186000.00
CERS cash_flow (quarterly, 2025-03-31) — End Cash Position: 20585000.00
CERS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 1071000.00
CERS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -956000.00
CERS cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
CERS income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -287000.00
CERS balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -266000.00
CERS balance_sheet (quarterly, 2025-03-31) — Goodwill: 1316000.00
CERS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1316000.00
CERS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 16148000.00
CERS income_statement (quarterly, 2025-03-31) — Gross Profit: 25424000.00
CERS income_statement (quarterly, 2025-03-31) — Interest Expense: 2110000.00
CERS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 2110000.00
CERS balance_sheet (quarterly, 2025-03-31) — Inventory: 48161000.00
CERS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 140465000.00
CERS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1189000.00
CERS cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 801000.00
CERS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 11941000.00
CERS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 64876000.00
CERS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 76817000.00
CERS cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 801000.00
CERS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 750000.00
CERS income_statement (quarterly, 2025-03-31) — Minority Interests: 1000.00
CERS balance_sheet (quarterly, 2025-03-31) — Net Debt: 65497000.00
CERS cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 497000.00
CERS income_statement (quarterly, 2025-03-31) — Net Income: -7717000.00
CERS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -7717000.00
CERS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -7718000.00
CERS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -7717000.00
CERS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -7717000.00
CERS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -7718000.00
CERS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -7718000.00
CERS income_statement (quarterly, 2025-03-31) — Net Interest Income: -2110000.00
CERS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -1077000.00
CERS cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 801000.00
CERS cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 801000.00
CERS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -2110000.00
CERS cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -56000.00
CERS balance_sheet (quarterly, 2025-03-31) — Net PPE: 16148000.00
CERS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 54176000.00
CERS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -4940000.00
CERS income_statement (quarterly, 2025-03-31) — Normalized Income: -7490270.00
CERS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -844000.00
CERS cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 497000.00
CERS income_statement (quarterly, 2025-03-31) — Operating Income: -5853000.00
CERS income_statement (quarterly, 2025-03-31) — Operating Revenue: 43239000.00
CERS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 191114000.00
CERS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 6091000.00
CERS balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 20097000.00
CERS balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -266000.00
CERS income_statement (quarterly, 2025-03-31) — Other Income Expense: 319000.00
CERS cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 717000.00
CERS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 27797000.00
CERS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 4027000.00
CERS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 606000.00
CERS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -5614000.00
CERS balance_sheet (quarterly, 2025-03-31) — Other Properties: 16148000.00
CERS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 61443000.00
CERS balance_sheet (quarterly, 2025-03-31) — Payables: 27677000.00
CERS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 34910000.00
CERS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 9702000.00
CERS income_statement (quarterly, 2025-03-31) — Pretax Income: -7644000.00
CERS cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 326000.00
CERS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -7964000.00
CERS balance_sheet (quarterly, 2025-03-31) — Receivables: 26344000.00
CERS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 17815000.00
CERS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 307000.00
CERS income_statement (quarterly, 2025-03-31) — Research And Development: 16605000.00
CERS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1073245000.00
CERS cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 6887000.00
CERS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 20286000.00
CERS balance_sheet (quarterly, 2025-03-31) — Share Issued: 191405932.00
CERS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 6635000.00
CERS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 55492000.00
CERS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 54176000.00
CERS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -60270.00
CERS income_statement (quarterly, 2025-03-31) — Tax Provision: 74000.00
CERS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
CERS balance_sheet (quarterly, 2025-03-31) — Total Assets: 206776000.00
CERS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 120368000.00
CERS balance_sheet (quarterly, 2025-03-31) — Total Debt: 99446000.00
CERS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 56242000.00
CERS income_statement (quarterly, 2025-03-31) — Total Expenses: 49092000.00
CERS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 150534000.00
CERS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 45261000.00
CERS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 80844000.00
CERS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -5853000.00
CERS income_statement (quarterly, 2025-03-31) — Total Unusual Items: -287000.00
CERS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -287000.00
CERS balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 291932.00
CERS cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 40000.00
CERS balance_sheet (quarterly, 2025-03-31) — Working Capital: 91825000.00
CERS income_statement (quarterly, 2025-06-30) — +Operating Expense: 32398000.00
CERS income_statement (quarterly, 2025-06-30) — +Total Revenue: 52445000.00
CERS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 30518000.00
CERS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 31394000.00
CERS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1134462000.00
CERS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 191301000.00
CERS income_statement (quarterly, 2025-06-30) — Basic EPS: -0.03
CERS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 20585000.00
CERS cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -477000.00
CERS cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -477000.00
CERS balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 14007000.00
CERS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 191000.00
CERS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 15991000.00
CERS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 78025000.00
CERS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -129000.00
CERS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1089000.00
CERS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -2446000.00
CERS cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 2805000.00
CERS cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 3279000.00
CERS cash_flow (quarterly, 2025-06-30) — Change In Inventory: -5877000.00
CERS cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -238000.00
CERS cash_flow (quarterly, 2025-06-30) — Change In Payable: 2805000.00
CERS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 6084000.00
CERS cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 1501000.00
CERS cash_flow (quarterly, 2025-06-30) — Change In Receivables: -4887000.00
CERS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -3417000.00
CERS cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -4887000.00
CERS cash_flow (quarterly, 2025-06-30) — Changes In Cash: -3664000.00
CERS balance_sheet (quarterly, 2025-06-30) — Common Stock: 191000.00
CERS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 55428000.00
CERS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 23470000.00
CERS balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 8272000.00
CERS balance_sheet (quarterly, 2025-06-30) — Current Assets: 168534000.00
CERS balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 2604000.00
CERS balance_sheet (quarterly, 2025-06-30) — Current Debt: 28125000.00
CERS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 30729000.00
CERS balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 2211000.00
CERS balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 2211000.00
CERS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 84358000.00
CERS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 344000.00
CERS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 344000.00
CERS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 191301000.00
CERS income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.03
CERS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -5707000.00
CERS income_statement (quarterly, 2025-06-30) — EBIT: -3489000.00
CERS income_statement (quarterly, 2025-06-30) — EBITDA: -3145000.00
CERS cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 210000.00
CERS cash_flow (quarterly, 2025-06-30) — End Cash Position: 17131000.00
CERS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -129000.00
CERS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -2923000.00
CERS cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 0.00
CERS income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -911000.00
CERS balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -273000.00
CERS balance_sheet (quarterly, 2025-06-30) — Goodwill: 1316000.00
CERS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1316000.00
CERS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 15556000.00
CERS income_statement (quarterly, 2025-06-30) — Gross Profit: 28975000.00
CERS income_statement (quarterly, 2025-06-30) — Interest Expense: 2150000.00
CERS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 2150000.00
CERS balance_sheet (quarterly, 2025-06-30) — Inventory: 54529000.00
CERS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 140319000.00
CERS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1089000.00
CERS cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: -98000.00
CERS balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 11403000.00
CERS balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 56766000.00
CERS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 68169000.00
CERS cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: -98000.00
CERS balance_sheet (quarterly, 2025-06-30) — Minority Interest: 742000.00
CERS income_statement (quarterly, 2025-06-30) — Minority Interests: 8000.00
CERS balance_sheet (quarterly, 2025-06-30) — Net Debt: 68900000.00
CERS cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 11000.00
CERS income_statement (quarterly, 2025-06-30) — Net Income: -5707000.00
CERS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -5707000.00
CERS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -5715000.00
CERS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -5707000.00
CERS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -5707000.00
CERS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -5715000.00
CERS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -5715000.00
CERS income_statement (quarterly, 2025-06-30) — Net Interest Income: -2150000.00
CERS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -612000.00
CERS cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -98000.00
CERS cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -98000.00
CERS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -2150000.00
CERS cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -31000.00
CERS balance_sheet (quarterly, 2025-06-30) — Net PPE: 15556000.00
CERS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 54112000.00
CERS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -2234000.00
CERS income_statement (quarterly, 2025-06-30) — Normalized Income: -4987310.00
CERS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -2446000.00
CERS cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 13000.00
CERS income_statement (quarterly, 2025-06-30) — Operating Income: -3423000.00
CERS income_statement (quarterly, 2025-06-30) — Operating Revenue: 52445000.00
CERS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 191296068.00
CERS balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 4586000.00
CERS balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 28125000.00
CERS balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -273000.00
CERS income_statement (quarterly, 2025-06-30) — Other Income Expense: -66000.00
CERS cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 816000.00
CERS balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 27665000.00
CERS balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 4374000.00
CERS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 845000.00
CERS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -7684000.00
CERS balance_sheet (quarterly, 2025-06-30) — Other Properties: 15556000.00
CERS balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 62034000.00
CERS balance_sheet (quarterly, 2025-06-30) — Payables: 30518000.00
CERS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 38790000.00
CERS balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 12628000.00
CERS income_statement (quarterly, 2025-06-30) — Pretax Income: -5639000.00
CERS cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
CERS cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -12513000.00
CERS balance_sheet (quarterly, 2025-06-30) — Receivables: 31394000.00
CERS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 23470000.00
CERS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 344000.00
CERS income_statement (quarterly, 2025-06-30) — Research And Development: 18900000.00
CERS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1078952000.00
CERS cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 11901000.00
CERS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 21182000.00
CERS balance_sheet (quarterly, 2025-06-30) — Share Issued: 191588000.00
CERS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 5681000.00
CERS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 55428000.00
CERS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 54112000.00
CERS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -191310.00
CERS income_statement (quarterly, 2025-06-30) — Tax Provision: 76000.00
CERS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
CERS balance_sheet (quarterly, 2025-06-30) — Total Assets: 213071000.00
CERS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 112194000.00
CERS balance_sheet (quarterly, 2025-06-30) — Total Debt: 98898000.00
CERS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 56170000.00
CERS income_statement (quarterly, 2025-06-30) — Total Expenses: 55868000.00
CERS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 156901000.00
CERS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 44537000.00
CERS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 72543000.00
CERS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -3423000.00
CERS income_statement (quarterly, 2025-06-30) — Total Unusual Items: -911000.00
CERS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -911000.00
CERS balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 291932.00
CERS cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -168000.00
CERS balance_sheet (quarterly, 2025-06-30) — Working Capital: 84176000.00
CERS income_statement (quarterly, 2025-09-30) — +Operating Expense: 26904000.00
CERS income_statement (quarterly, 2025-09-30) — +Total Revenue: 52698000.00
CERS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 25468000.00
CERS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 29772000.00
CERS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1140416000.00
CERS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 191830000.00
CERS income_statement (quarterly, 2025-09-30) — Basic EPS: 0.00
CERS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 17131000.00
CERS cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1833000.00
CERS cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -1833000.00
CERS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 13282000.00
CERS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 192000.00
CERS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 15670000.00
CERS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 78512000.00
CERS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 320000.00
CERS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -2509000.00
CERS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 1927000.00
CERS cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -4480000.00
CERS cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -787000.00
CERS cash_flow (quarterly, 2025-09-30) — Change In Inventory: 704000.00
CERS cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 70000.00
CERS cash_flow (quarterly, 2025-09-30) — Change In Payable: -4480000.00
CERS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -5267000.00
CERS cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -1258000.00
CERS cash_flow (quarterly, 2025-09-30) — Change In Receivables: 1438000.00
CERS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -4313000.00
CERS cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 1438000.00
CERS cash_flow (quarterly, 2025-09-30) — Changes In Cash: -262000.00
CERS balance_sheet (quarterly, 2025-09-30) — Common Stock: 192000.00
CERS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 61463000.00
CERS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 24558000.00
CERS balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 7662000.00
CERS balance_sheet (quarterly, 2025-09-30) — Current Assets: 167127000.00
CERS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 2613000.00
CERS balance_sheet (quarterly, 2025-09-30) — Current Debt: 36249000.00
CERS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 38862000.00
CERS balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 2281000.00
CERS balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 2281000.00
CERS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 88433000.00
CERS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 382000.00
CERS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 382000.00
CERS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 191830000.00
CERS income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.00
CERS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -19000.00
CERS income_statement (quarterly, 2025-09-30) — EBIT: 2184000.00
CERS income_statement (quarterly, 2025-09-30) — EBITDA: 2566000.00
CERS cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -60000.00
CERS cash_flow (quarterly, 2025-09-30) — End Cash Position: 16809000.00
CERS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 320000.00
CERS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 94000.00
CERS cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 3000.00
CERS cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00
CERS income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -28000.00
CERS balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -174000.00
CERS balance_sheet (quarterly, 2025-09-30) — Goodwill: 1316000.00
CERS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1316000.00
CERS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 14665000.00
CERS income_statement (quarterly, 2025-09-30) — Gross Profit: 28140000.00
CERS income_statement (quarterly, 2025-09-30) — Interest Expense: 2119000.00
CERS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 2119000.00
CERS balance_sheet (quarterly, 2025-09-30) — Inventory: 53139000.00
CERS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 146367000.00
CERS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -2509000.00
CERS cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: -1000.00
CERS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 10669000.00
CERS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 48655000.00
CERS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 59324000.00
CERS cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: -1000.00
CERS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 741000.00
CERS income_statement (quarterly, 2025-09-30) — Minority Interests: 1000.00
CERS balance_sheet (quarterly, 2025-09-30) — Net Debt: 69234000.00
CERS cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -361000.00
CERS income_statement (quarterly, 2025-09-30) — Net Income: -19000.00
CERS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -19000.00
CERS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -20000.00
CERS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -19000.00
CERS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -19000.00
CERS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -20000.00
CERS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -20000.00
CERS income_statement (quarterly, 2025-09-30) — Net Interest Income: -2119000.00
CERS cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -676000.00
CERS cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -1000.00
CERS cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -1000.00
CERS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -2119000.00
CERS cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 52000.00
CERS balance_sheet (quarterly, 2025-09-30) — Net PPE: 14665000.00
CERS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 60147000.00
CERS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 2594000.00
CERS income_statement (quarterly, 2025-09-30) — Normalized Income: 3120.00
CERS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 1927000.00
CERS cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -358000.00
CERS income_statement (quarterly, 2025-09-30) — Operating Income: 1236000.00
CERS income_statement (quarterly, 2025-09-30) — Operating Revenue: 52698000.00
CERS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 191745068.00
CERS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 5704000.00
CERS balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 36249000.00
CERS balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -174000.00
CERS income_statement (quarterly, 2025-09-30) — Other Income Expense: 948000.00
CERS cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 682000.00
CERS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 32077000.00
CERS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 5224000.00
CERS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 976000.00
CERS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: -7539000.00
CERS balance_sheet (quarterly, 2025-09-30) — Other Properties: 14665000.00
CERS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 62842000.00
CERS balance_sheet (quarterly, 2025-09-30) — Payables: 25468000.00
CERS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 33130000.00
CERS balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 14160000.00
CERS income_statement (quarterly, 2025-09-30) — Pretax Income: 65000.00
CERS cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 269000.00
CERS cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -7288000.00
CERS balance_sheet (quarterly, 2025-09-30) — Receivables: 29772000.00
CERS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 24558000.00
CERS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 382000.00
CERS income_statement (quarterly, 2025-09-30) — Research And Development: 15825000.00
CERS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1078971000.00
CERS cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 6612000.00
CERS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 18618000.00
CERS balance_sheet (quarterly, 2025-09-30) — Share Issued: 192037000.00
CERS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 5624000.00
CERS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 61463000.00
CERS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 60147000.00
CERS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -5880.00
CERS income_statement (quarterly, 2025-09-30) — Tax Provision: 85000.00
CERS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CERS balance_sheet (quarterly, 2025-09-30) — Total Assets: 215185000.00
CERS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 110118000.00
CERS balance_sheet (quarterly, 2025-09-30) — Total Debt: 98186000.00
CERS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 62204000.00
CERS income_statement (quarterly, 2025-09-30) — Total Expenses: 51462000.00
CERS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 152981000.00
CERS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 48058000.00
CERS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 64548000.00
CERS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 1236000.00
CERS income_statement (quarterly, 2025-09-30) — Total Unusual Items: -28000.00
CERS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -28000.00
CERS balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 291932.00
CERS cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -70000.00
CERS balance_sheet (quarterly, 2025-09-30) — Working Capital: 78694000.00
CERS income_statement (annual, 2025-12-31) — +Operating Expense: 120969000.00
CERS income_statement (quarterly, 2025-12-31) — +Operating Expense: 30390000.00
CERS income_statement (annual, 2025-12-31) — +Total Revenue: 206133000.00
CERS income_statement (quarterly, 2025-12-31) — +Total Revenue: 57751000.00
CERS balance_sheet (annual, 2025-12-31) — Accounts Payable: 28008000.00
CERS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 28008000.00
CERS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 30374000.00
CERS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 30374000.00
CERS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -19673000.00
CERS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -19673000.00
CERS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1145343000.00
CERS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1145343000.00
CERS cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
CERS income_statement (annual, 2025-12-31) — Basic Average Shares: 190594000.00
CERS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 192109000.00
CERS income_statement (annual, 2025-12-31) — Basic EPS: -0.08
CERS income_statement (quarterly, 2025-12-31) — Basic EPS: -0.01
CERS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 21361000.00
CERS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 16809000.00
CERS cash_flow (annual, 2025-12-31) — Capital Expenditure: -3729000.00
CERS cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1307000.00
CERS cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -3729000.00
CERS cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -1307000.00
CERS balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 13058000.00
CERS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 13058000.00
CERS balance_sheet (annual, 2025-12-31) — Capital Stock: 192000.00
CERS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 192000.00
CERS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 19961000.00
CERS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 19961000.00
CERS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 82879000.00
CERS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 82879000.00
CERS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 231000.00
CERS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1031000.00
CERS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -6165000.00
CERS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1378000.00
CERS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 4837000.00
CERS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 6200000.00
CERS cash_flow (annual, 2025-12-31) — Change In Account Payable: 5725000.00
CERS cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 2363000.00
CERS cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 4275000.00
CERS cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 4209000.00
CERS cash_flow (annual, 2025-12-31) — Change In Inventory: -14682000.00
CERS cash_flow (quarterly, 2025-12-31) — Change In Inventory: -3176000.00
CERS cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -124000.00
CERS cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -1007000.00
CERS cash_flow (annual, 2025-12-31) — Change In Payable: 5725000.00
CERS cash_flow (quarterly, 2025-12-31) — Change In Payable: 2363000.00
CERS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 10000000.00
CERS cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 6572000.00
CERS cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -1627000.00
CERS cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 442000.00
CERS cash_flow (annual, 2025-12-31) — Change In Receivables: -396000.00
CERS cash_flow (quarterly, 2025-12-31) — Change In Receivables: -608000.00
CERS cash_flow (annual, 2025-12-31) — Change In Working Capital: -6829000.00
CERS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 2223000.00
CERS cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -396000.00
CERS cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -608000.00
CERS cash_flow (annual, 2025-12-31) — Changes In Cash: -1097000.00
CERS cash_flow (quarterly, 2025-12-31) — Changes In Cash: 3791000.00
CERS balance_sheet (annual, 2025-12-31) — Common Stock: 192000.00
CERS balance_sheet (quarterly, 2025-12-31) — Common Stock: 192000.00
CERS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 64224000.00
CERS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 64224000.00
CERS balance_sheet (annual, 2025-12-31) — Construction In Progress: 2901000.00
CERS balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 2901000.00
CERS income_statement (annual, 2025-12-31) — Cost Of Revenue: 93845000.00
CERS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 28002000.00
CERS balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 7010000.00
CERS balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 7010000.00
CERS balance_sheet (annual, 2025-12-31) — Current Assets: 174384000.00
CERS balance_sheet (quarterly, 2025-12-31) — Current Assets: 174384000.00
CERS balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 2905000.00
CERS balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 2905000.00
CERS balance_sheet (annual, 2025-12-31) — Current Debt: 43343000.00
CERS balance_sheet (quarterly, 2025-12-31) — Current Debt: 43343000.00
CERS balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 46248000.00
CERS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 46248000.00
CERS balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 1274000.00